Condition
HPV-Related Squamous Cell Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 6 HPV-Related Squamous Cell Carcinoma clinical trials that are recruiting, at sites in 2 countries (most in United States (6), Puerto Rico (1)). By phase: Phase 2 (4), Phase 1/2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 2Countries
Newest HPV-Related Squamous Cell Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Probiotics to Treat Anal HSIL in HIV Patients | Phase 2 | San Francisco, California and 1 other locations | Recruiting | Apr 29, 2025 |
| Comparing personalized radiation therapy to standard radiation therapy for HPV-positive throat cancer | Phase 3 | Hartford, Connecticut and 8 other locations | Recruiting | Aug 20, 2024 |
| Immunotherapy using E7 TCR-T cells for HPV-related cancers | Phase 2 | Bethesda, Maryland and 2 other locations | Recruiting | Jan 17, 2023 |
| E7 T-cell therapy for advanced HPV-related cancers | Phase 1/2 | New Brunswick, New Jersey and 1 other locations | Recruiting | Dec 7, 2022 |
| Using Cemiplimab with or without chemotherapy for HPV-related head and neck cancer | Phase 2 | Baltimore, Maryland | Recruiting | Aug 3, 2021 |
| Tailored treatment for HPV-positive oropharyngeal cancer using blood tests | Phase 2 | Boston, Massachusetts and 1 other locations | Recruiting | May 25, 2021 |
All recruiting trials (6)
-
Probiotics to Treat Anal HSIL in HIV Patients
In people with HIV who have anal HSIL, this study tests whether a probiotic called EXE-346 can help clear lesions or reduce progression, compared with placebo.
-
Comparing personalized radiation therapy to standard radiation therapy for HPV-positive throat cancer
This study is testing if a personalized radiation treatment with a lower dose can help people with HPV-positive throat cancer feel better and have fewer side effects compared to standard radiation therapy.
-
Immunotherapy using E7 TCR-T cells for HPV-related cancers
This study is testing a new immunotherapy using E7 TCR-T cells to see if it can help people with advanced HPV-related cancers like cervical and throat cancer feel better and improve their health.
-
E7 T-cell therapy for advanced HPV-related cancers
This study is testing a new treatment using specially modified immune cells to see if it can help people with advanced cancers linked to HPV feel better and live longer.
-
Using Cemiplimab with or without chemotherapy for HPV-related head and neck cancer
This study is testing if a new immunotherapy called Cemiplimab, with or without chemotherapy, can help people with HPV-related head and neck cancer while making treatment easier and improving their quality of life.
-
Tailored treatment for HPV-positive oropharyngeal cancer using blood tests
This study is testing a new way to tailor treatment for people with HPV-related throat cancer by using blood tests to see if adjusting their radiation and chemotherapy can improve their outcomes.
Related topics
Quick answers
How many HPV-Related Squamous Cell Carcinoma clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (6 trials), Puerto Rico (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4, Phase 1/2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.